Clinical Trial Update: Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase II trial of pegylated liposomal doxorubicin as second-line or later therapy for Mullerian carcinomas, including epithelial ovarian cancer, fallopian tube …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pegylated liposomal doxorubicin hydrochloride injection (pegylated liposomal doxorubicin hydrochloride)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED